FDA Investigator John A Kadavil, PhD

John A Kadavil, PhD has conducted inspections on 14 sites in 4 countries as of 20 May 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
14
Last Inspection Date:
20 May 2019
Investigator Role:
FDA Investigator
Redica ID:
100005035
Countries of Inspections:
United States of America, Canada, India, Israel
FDA Investigators that have inspected at least one site in common with John A Kadavil, PhD:
Albert F Peacock, PhD, Allen F Hall, Amanda E Lewin, PhD, Amber G Chung, Ana P Barido, Andrea A Branche, Arianne L Motter, Arindam Dasgupta, PhD, Barbara A Rusin, Barbara M Frazier, Brandon L Mariner, Brooke K Higgins, Brunilda Torres, Candice C Mandera, Candice J Cortes, Carl J Montgomery, Carol Rivera Lopez, PhD, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Cote, RIC, Chase Bourke, PhD, Christine M Whitby, CSO, Clint Mitchell, Corey K Reno, Courtney N Long, Craig A Garmendia, Cynthia A Harris, MD, RN, David K Glasgow, David L Chon, Denise L Burosh, Dianne H Milazzo, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Elise A Murphy, Erin L Mcfiren, Erin M Mcdowell, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Geoffrey K Kilili, George C Amedro, Gifford Whitehurst, Jr, Gulshan R Anand, Himanshu Gupta, PhD, Hugh M Mcclure, II, Huixia Zhang, Hyojong Kwon, PhD, Jacqueline A O'shaughnessy, PhD, James R Fleckenstein, Jennifer A Longie Vollom, Jennifer L Sheehan, Jodi M Gatica, Jyoti B Patel, PhD, Kalavati Suvarna, PhD, Karen M Cooper, Karen M Kondas, Kip J Hanks, Kirtida Patel, Lakisha M Williams, Larry K Austin, Laura E Garcia, Lawrence Y Lee, PhD, LCDR Matthew R Mcnew, MPH, REHS/RS, Li Hongpaul Yeh, PhD, Linda R Kuchenthal, Lisa B Orr, Lisa P Oakes, Lori A Gioia, Margaret M Annes, Martin K Yau, PhD, Matthew J Gretkierewicz, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael J Nerz, Mike M Rashti, Mohsen Rajabi Abhari, FDA, Nancy A Bellamy, Nathaniel R Esaw, Nicola M Fenty Stewart, Nilufer M Tampal, PhD, Patrick D Stone, MS, Paula M Laplant, Rebecca T Davis, Robert Barron, Robert C Steyert, Ronald R Ruff, Ruben C Ayala, PharmD, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Samuel H Chan, PharmD, Scott B Laufenberg, Sean Y Kassim, PhD, Seongeun Cho (Julia), PhD, Sherry L Secrist, BLT DO, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacey A Priest, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Susan D Yuscius, Tamal K Chakraborti, PhD, Vlada Matusovsky, William H Linkroum, Wr Bowman, Xikui Chen (nmi), PhD, Yih Chain Huang, PhD, Young M Yoon

John A Kadavil, PhD's Documents

Publish Date Document Type Title
February, 2005 FDA 483 Biovail Contract Research - Form 483, 2005-02-04
June, 2007 FDA 483 PPD Development, L.P. - Form 483, 2007-06-06
December, 2003 FDA 483 Merck & Company, Inc. - Form 483, 2003-12-19
December, 2010 FDA 483 Cetero Research - Form 483, 2010-12-10
February, 2005 EIR Syneos Health Clinique Inc - EIR, 2005-02-18
September, 2003 EIR PPD Development, L.P. - EIR, 2003-09-12
September, 2008 FDA 483 ACCUTEST RESEARCH LABORATORIES ( I ) - Form 483, 2008-09-01
July, 2004 FDA 483 PPD Development, L.P. - Form 483, 2004-07-21
April, 2009 FDA 483 BASi Gaithersburg, LLC - Form 483, 2009-04-22
September, 2009 FDA 483 Human Genome Sciences Inc - Form 483, 2009-09-21
June, 2007 EIR PPD Development, L.P. - EIR, 2007-06-06
September, 2005 EIR BASi Gaithersburg, LLC - EIR, 2005-09-12
July, 2004 EIR PPD Development, L.P. - EIR, 2004-07-21
September, 2008 EIR ACCUTEST RESEARCH LABORATORIES ( I ) - EIR, 2008-10-16
July, 2004 FDA 483 Response PPD Development, L.P. - Form 483R, 2004-08-16
December, 2003 EIR Merck & Company, Inc. - EIR, 2003-12-19
October, 2010 FDA 483 Human Genome Sciences Inc - Form 483, 2010-09-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more